710 Cypress Creek Parkway, Houston, TX, 77090 · (281) 440-1000
Beds
298
FY 2025
Star rating
2 of 5
Patient survey: 2 of 5
Net patient revenue
$448.3M
FY 2025
Net income
$59.7M
Patient care margin 13.1%
Discharges
16,601
Occupancy 80.5%
Clinicians
263
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $448.3M | $389.4M | 13.1% | $59.7M | 16,601 | $61.2M | 8.7% | 8.4% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for heart attack patients | 12.6% | US median 11.8% |
| Death rate for heart failure patients | 9.9% | US median 11% |
| Hospital-wide death rate within 30 days | 3.2% | US median 3.9% |
| Death rate for pneumonia patients | 13.2% | US median 15.2% |
| Death rate for stroke patients | 10.2% | US median 11.6% |
| Readmission rate for COPD | 20.2% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $445.4M | $395.9M | 11.1% | $50.6M | 16,286 | $56.9M | 9.1% | 6.0% |
| 2023 | $343.2M | $326.2M | 4.9% | $17.9M | 14,822 | $48.9M | 10.3% | 9.2% |
| 2022 | $322.5M | $311.2M | 3.5% | $12.4M | 14,517 | $47.1M | 10.8% | 9.0% |
| 2021 | $325.6M | $310.5M | 4.7% | $11.6M | 14,511 | $47.6M | 13.1% | 10.0% |
| 2020 | $252.4M | $273.6M | -8.4% | -$15.7M | 14,685 | $49.3M | 14.3% | 11.9% |
| US median 19.8% |
| Readmission rate after a heart attack | 15% | US median 14.4% |
| Readmission rate for heart failure | 22.8% | US median 21.3% |
| Readmission rate after hip or knee replacement | 5.7% | US median 5.8% |
| Readmission rate for pneumonia | 18.1% | US median 17.2% |
| Complications after hip or knee replacement | 3.7% | US median 4.1% |
| Serious complications (patient safety composite) | 1.14 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.00 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.25 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 0.79 | US median 0.72 |
| MRSA bloodstream infections (ratio to expected) | 0.00 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.37 | US median 0.40 |
| Doctors always communicated well | 70% | US median 79% |
| Nurses always communicated well | 73% | US median 80% |
| Patient survey summary star rating | 2 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 56% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 62% | US median 72% |
| Room and bathroom always clean | 69% | US median 73% |
| Patients who would definitely recommend the hospital | 59% | US median 71% |
| Patients who left the emergency department before being seen | 1% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 147 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 10% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 74% | US median 65% |
| Healthcare workers given the flu vaccine | 66% | US median 79% |
| 49 |
| $152,717.73 |
| $14,515.73 |
| $12,400.10 |
| DRG 682 RENAL FAILURE WITH MCC | 34 | $124,070.59 | $14,450.79 | $11,457.18 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 32 | $129,840.88 | $14,558.34 | $10,642.23 |
| DRG 064 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC | 26 | $274,545.62 | $17,243.46 | $15,695.20 |
| DRG 683 RENAL FAILURE WITH CC | 26 | $100,346.77 | $10,807.54 | $6,629.69 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 26 | $187,181.58 | $16,440.35 | $13,076.55 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 20 | $754,984.60 | $48,577.15 | $40,556.82 |
| DRG 189 PULMONARY EDEMA AND RESPIRATORY FAILURE | 19 | $97,959.32 | $13,542.32 | $9,973.97 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 18 | $118,635.44 | $11,796.39 | $7,681.44 |
| DRG 481 HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH CC | 18 | $390,825.67 | $18,355.72 | $15,801.33 |
| DRG 552 MEDICAL BACK PROBLEMS WITHOUT MCC | 14 | $156,439.86 | $10,673.79 | $7,114.44 |
| DRG 641 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC | 14 | $73,887.07 | $8,448.29 | $5,829.71 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 13 | $122,835.15 | $9,396.62 | $5,985.69 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5373 Level 3 Urology and Related Services | 28 | 25 | $1,448.45 | $1,516.28 |
| APC 5491 Level 1 Intraocular Procedures | 20 | 13 | $1,721.64 | $1,751.67 |
| APC 5302 Level 2 Upper GI Procedures | 19 | 17 | $1,406.53 | $1,444.50 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 18 | 18 | $1,197.79 | $1,219.56 |
| APC 8011 Comprehensive Observation Services | 17 | 16 | $2,022.21 | $2,090.36 |
| APC 5374 Level 4 Urology and Related Services | 16 | 12 | $2,575.53 | $2,629.24 |
| APC 5114 Level 4 Musculoskeletal Procedures | 15 | 15 | $5,284.05 | $5,338.75 |
| APC 5361 Level 1 Laparoscopy and Related Services | 14 | 13 | $4,262.78 | $4,357.80 |
| APC 5113 Level 3 Musculoskeletal Procedures | 13 | 13 | $2,391.34 | $2,373.24 |
| APC 5115 Level 5 Musculoskeletal Procedures | 11 | 11 | $10,554.73 | $10,771.69 |
| APC 5184 Level 4 Vascular Procedures | 11 | - | $4,059.89 | $3,945.82 |
| APC 5414 Level 4 Gynecologic Procedures | - | - | - | $2,389.24 |
Reported payments to this teaching hospital
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
HCA Houston Healthcare Northwest is a for-profit short-term acute care hospital in Houston, TX with 298 beds, part of HCA Healthcare and a 2-star overall rating.
HCA Houston Healthcare Northwest in Houston, TX has 298 beds (fiscal year 2025 cost report); 423 beds are certified for Medicare. It discharged 16,601 inpatients that year, with 80.5% of its beds in use on average.
In fiscal year 2025 (ending 2025-05-31), HCA Houston Healthcare Northwest reported net patient revenue of $448.3M and operating expenses of $389.4M, a margin on patient care of 13.1%. After other income and expenses its net income was $59.7M (13.3% of revenue), so it made a profit that year.
HCA Houston Healthcare Northwest is part of HCA Healthcare (listed company, ticker HCA), a health system with 163 hospitals based in Nashville, TN. It is a for-profit hospital.
HCA Houston Healthcare Northwest has an overall rating of 2 out of 5 stars in the official hospital quality ratings. Patients rate it 2 out of 5 stars in the patient survey.
Yes, HCA Houston Healthcare Northwest provides emergency services.
263 Medicare clinicians list HCA Houston Healthcare Northwest as a hospital they work at, most often in Internal Medicine, Emergency Medicine, Diagnostic Radiology.
In 2024, HCA Houston Healthcare Northwest had 661 Medicare inpatient stays in 26 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 169 stays; Medicare paid $17,354.09 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $2,629 in payments to HCA Houston Healthcare Northwest as a teaching hospital ($2,629 general and - for research) from 4 companies.